MEEKER DAVID P (President and CEO) sold 17.8% of their position (43.62K shares) of RHYTHM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $2.84M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/5/2025ACC: 0001104659-25-056838
DirectorOfficer· President and CEO
Since Feb 2026
-43.62K
Net shares
Net seller
$2.84M
Total sold
2
Open market trades
0B · 2S
4
Total transactions
43.62K acquired · 87.24K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+43.62K
Price / share
$4.59
Trade value
$200.22K
% of position
21.6%
6/3/2025
201.82K→245.44K
Common Stock
Direct
Shares
−43.35K
Price / share
$65.04
Trade value
$2.82M
% of position
17.7%
6/3/2025
245.44K→202.10K
Common Stock
Direct
Shares
−274.00
Price / share
$65.60
Trade value
$17.98K
% of position
0.1%
6/3/2025
202.10K→201.82K
Total
Net shares
+0.00
Net value
-$2.64M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/3/2025 | M · Option Exercise | +43.62K | $4.59 | $200.22K | 21.6% | 201.82K | 245.44K |
| Common Stock Direct | 6/3/2025 | S · Sale | −43.35K | $65.04 | $2.82M | 17.7% | 245.44K | 202.10K |
| Common Stock Direct | 6/3/2025 | S · Sale | −274.00 | $65.60 | $17.98K | 0.1% | 202.10K | 201.82K |
| Total | +0.00 | -$2.64M | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
43.62K shares
Shares
−43.62K
Strike price
4.59
Held after
0.00
Exercisable
—
6/3/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock43.62K shares | 6/3/2025 | M · Option Exercise | −43.62K | 4.59 | — | 0.00 |